Patients Moving beyond intent: Building more diverse clinical trials Improving representation is not simply about increasing awareness or setting enrolment targets. It requires identifying and removing the barriers.
Patients Progress with England’s Single National Formulary after a ye... Leela Barham digs deeper into the progress update from NHS England in July 2026.
Patients Moving from patient centricity to patient partnership The desire for patients to be active partners in research challenges how organisations approach patient engagement.
Patients End-of-life choice means little without end-of-life support A strong end-of-life care system does not wait until the final days to step in.
Patients ASCO 2026: New hope in AL amyloidosis, with Dr Hans Lee A phase 1/2 trial in AL amyloidosis saw 100% of patients obtaining at least a very good partial response with 90% obtaining a complete response.
Patients Sponsored Designing global PSPs for the real world How integrating strategic design with implementation expertise can help create more scalable, locally relevant, and effective global PSPs.
News Novartis sets sights on new oral MS drug after phase 3 wins Novartis' oral BTK inhibitor remibrutinib has shown efficacy in a pair of phase 3 trials in multiple sclerosis, boosting its blockbuster credentials.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.